Posted on January 24, 2012
Results from a National Cancer Institute (NCI) sponsored multi-center study published in the Journal of the American Medical Association on January 25, 2012, provides strong evidence that BRCA1 and BRCA2 gene mutation carriers with ovarian cancer were more likely to survive in the five years following diagnosis than were women with ovarian cancer who do not have mutations in these genes.
The National Cancer Institute (NCI) press note on the study
News article in NCI’s bi-weekly newsletter the Cancer Bulletin
Short research highlight in the DCEG Linkage Newsletter
To request an interview with a DCEG investigator, contact the NCI Office of Media Relations: